BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE. The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges. Risk Manag Healthc Policy 2021;14:901-10. [PMID: 33707976 DOI: 10.2147/RMHP.S300656] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Maia LO, Daldegan-bueno D, Wießner I, Araujo DB, Tófoli LF. Ayahuasca's therapeutic potential: What we know – and what not. European Neuropsychopharmacology 2023;66:45-61. [DOI: 10.1016/j.euroneuro.2022.10.008] [Reference Citation Analysis]
2 Miller AH, Raison CL. Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies. Mol Psychiatry 2022. [DOI: 10.1038/s41380-022-01887-y] [Reference Citation Analysis]
3 Bouso JC, Andión Ó, Sarris JJ, Scheidegger M, Tófoli LF, Opaleye ES, Schubert V, Perkins D. Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Glob Public Health 2022;2:e0000438. [DOI: 10.1371/journal.pgph.0000438] [Reference Citation Analysis]
4 Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, dos Santos RG. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant. Biomolecules 2022;12:1618. [DOI: 10.3390/biom12111618] [Reference Citation Analysis]
5 Sottile RJ, Vida T. A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy. Front Psychiatry 2022;13:991753. [DOI: 10.3389/fpsyt.2022.991753] [Reference Citation Analysis]
6 Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review. Curr Psychiatry Rep 2022. [PMID: 35953638 DOI: 10.1007/s11920-022-01361-0] [Reference Citation Analysis]
7 Ona G, Kohek M, Bouso JC. The modern clinical use of hallucinogens. What can we learn from the natural product research? Natural Product Research. [DOI: 10.1080/14786419.2022.2103697] [Reference Citation Analysis]
8 Pöllänen E, Osika W, Stenfors CUD, Simonsson O. Classic Psychedelics and Human–Animal Relations. IJERPH 2022;19:8114. [DOI: 10.3390/ijerph19138114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M. New Paradigms of Old Psychedelics in Schizophrenia. Pharmaceuticals (Basel) 2022;15:640. [PMID: 35631466 DOI: 10.3390/ph15050640] [Reference Citation Analysis]
10 James E, Keppler J, L Robertshaw T, Sessa B. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Hum Psychopharmacol 2022;37:e2835. [PMID: 35175662 DOI: 10.1002/hup.2835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Rossi GN, Hallak JEC, Bouso Saiz JC, dos Santos RG. Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Expert Opinion on Drug Safety. [DOI: 10.1080/14740338.2022.2066650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
12 Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y. Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness. Journal of Palliative Medicine. [DOI: 10.1089/jpm.2022.0036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Andrews T, Wright K. The frontiers of new psychedelic therapies: A survey of sociological themes and issues. Sociology Compass 2022;16. [DOI: 10.1111/soc4.12959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J. Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead. Front Psychiatry 2021;12:737738. [PMID: 34803761 DOI: 10.3389/fpsyt.2021.737738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Li Q, Morris JS, Facchini PJ, Yeaman S. Partial genome assembly of the medicinal plant Ephedra sinica.. [DOI: 10.1101/2021.06.02.446745] [Reference Citation Analysis]
16 Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. Molecules 2021;26:2451. [PMID: 33922330 DOI: 10.3390/molecules26092451] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]